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ABSTRACT 
Cardiac pacemakers and implantable cardioverter defibrillators (ICD) are standard 
therapy for patients with a bradyarrhythmia, tachyarrhythmia or heart failure (HF) with a 
left bundle branch block (LBBB) (Wilkoff, et al., 2008). Millions of cardiac implantable 
electronic devices (CIED) have been implanted worldwide and this clinical practice has 
improved the quality of life for millions (Epstein, DiMarco, & Ellenbogen, 2008).  With 
the increase of implants there has been an increase in the infection rates (Klug et al., 
2007). Research studies have evaluated pre-procedure, during procedure and after 
procedure risk and protocols. Studies have also evaluated operative factors, procedural 
related factors, intravenous preoperative and postoperative prophylaxis  and topical 
antibiotics (Padfield et al., 2015). There is no consensus on the use of oral antibiotics post 
CIED implant at discharge to reduce the rate of infection. With no clear consensus, 
protocols vary greatly among institutions and clinical practice to reduce the rate of 
infections. The purpose of this study was to address gaps in the literature and determine 
whether prophylactic oral post-operative antibiotic administration reduced the incidence 
of infection related to device implantation. In addition, an evaluation of institutional 
infection prevention program. The study describes the clinical practice at a single center 
tertiary care hospital for implanting CIED’s including initial and replacement pacemaker, 
ICD’s and loop recorders (ILR). The study compared infection rates before and after the 
institution of prophylactic oral post-operative antibiotics. 
Statistically- Sample size N= 1200 ± 25 between 2013 and 2016, ICD’s 50.6%, Pacemakers 42.2%, ILR 5.5, lead revision 1.8%. Both pacemaker and ICD initial implants were 64.3%, replacement 35.2% and upgrades 11%. Patient characteristics were male 57.9%, female 42.1%, mean age was 65.8 years old. Use of oral antibiotics consisted of Keflex 8.2%, Doxycycline 17.6%, other 3.8% and no antibiotic usage was 70.5%.  
Findings note the use of prophylactic post-operative oral antibiotics in whole was 
not statistically significant with CI of 95%. Statistical significance (P .030) was noted in 
provider and incisional assessment  and interaction between provider and antibiotic (P 
.019). No statistical difference was noted in implants between years for incisional site 
assessment. 
 Recommendations include adherence to pre-operative, peri-operative and post-
operative protocols. In addition we recommend adherence to infection prevention by 
consistently cleaning device programmer heads with antiseptic wipes between patients 
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CHAPTER 1: INTRODUCTION 
The population of interest for this project was patients implanted with 
Cardiac Implantable electronic devices (CIED), pacemaker or an implantable 
cardioverter defibrillator (ICD) for an arrhythmia. Cardiac implantable electronic 
devices are life saving devices, the clinical benefit of CIED’s has been long 
proven through numerous studies. Cardiac pacemakers and ICD’s are standard 
therapy for patients with a bradyarrhythmia, tachyarrhythmia, or heart failure with 
a left bundle branch block (Wilkoff, et al., 2008). Millions of CIED’s have been 
implanted worldwide and this clinical practice has improved the quality of life for 
millions (Epstein, DiMarco, & Ellenbogen, 2008).   
With the increase of implants there has been an increase in the infection 
rates (Klug et al., 2007). Research studies have evaluated pre-procedure, during 
procedure and after procedure risk and protocols and risk factors. Few studies 
have assessed or did not identify a consensus on prophylactic use of oral post-op 
antibiotics after CEID implantation at hospital discharge to further reduce the rate 
of infection. Additional studies that specifically investigate the effectiveness of of 
this practice needed. 
 The aim of this project was to evaluate the efficacy of prophylactic post-
operative oral antibiotics at discharge and reduction in the rate of infection after 
device implantation.   
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Problem statement 
A surgical site infection is an infection that occurs after surgery in the area 
of the body where procedure was performed. Surgical site infection is defined by 
the Center for disease control as superficial incisional, deep incisional or organ or 
space infection (CDC, 2016;  De Angelis, 2011; Metais et al., 2011)  
 (Appendix 1).  
Surgical site infections remain a significant cause of morbidity, prolonged 
hospitalization, and death (Skoufalos, Clarke, & Napp, 2012).  Surgical site 
infections are associated with a mortality which can be directly attributable to the 
SSI (Awad, 2012).  Infection rates in pacemakers and ICD’s range from 1% to 7%  
for initial implants and replacements  respectively (Skoufalos, Clarke & Napp, 
2012).  There are known risk factors associated with an increased risk for surgical 
site infection, diabetes, anticoagulation resulting in hematoma, end stage renal 
disease and temporary pacemaker wires (Rohacek & Baddour, 2015).  
Studies have evaluated operative factors, procedural related factors, 
intravenous preoperative and postoperative prophylaxis  and topical antibiotics 
(Padfield et al., 2015). The Prevention of arrhythmia device infection trial 
(PADIT) utilized a combination approach of preoperative antibiotics,  wound 
pocket irrigation with an antibiotic and a 2-day course of oral postoperative 
antibiotics in a targeted population of higher risk procedures (Connolly et al., 
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2013). With no clear consensus, protocols vary greatly among institutions and 
clinical practice to reduce the rate of infections.   
Objectives and Aims 
 
The study was to determine whether prophylactic oral post-operative 
antibiotic administration reduces the incidence of infection related to device 
implantation. In addition, evaluate institutional infection prevention program. The 
study aimed to: 
1. Describe the clinical practice at a tertiary care hospital for implanting 
CIED’s including initial and replacement pacemaker, ICD’s and ILR.  
2. Compare infection rates before and after the institution of prophylactic oral 
post-operative antibiotics. Evaluate infection rate and interventions  
3. Develop a protocol that includes or excludes prophylactic oral post-
operative antibiotics based on findings.  
CHAPTER 2: LITERATURE REVIEW 
A literature search for key words; cardiac electronic implantable device, 
implantable cardiac defibrillator, pacemaker and infection was completed. Articles 
were identified relevant to this project with a compendium summarized.  Studies 
identified ranged from one year to forty years, sample sizes were as small as 
thirteen up to over four thousand patients. Study designs were prospective, 
retrospective and mixed method.  
 13
Khalighi, Aung and Elmi (2014) evaluated the efficacy of topical antibiotic 
prophylaxis in the prevention of surgical site infection after CEID implantation 
procedures. A prospective randomized, placebo-controlled, single-center, single-
operator study randomized 1,008 patients into four groups and received various 
topical prophylaxes after procedure. Fifty-eight patients developed surgical site 
inﬂammation and infection. Fourteen patients had culture-positive wound 
infections. Among them, 13 patients had superﬁcial wound infections with 
Staphylococcus species (Khalighi, Aung & Elmi, 2014) 
Metais et al. utilized a standardized survey form adapted from a prior 
research study, a prospective evaluation of pacemaker lead endocarditis study 
(people) cohort. The study noted that optimal compliance with antibiotic 
prophylaxis was not reached and attempts should be made to obtain full adherence 
to preventive measures in device implantation (2011). Uslan et al. Conducted an 
analysis to identify contributing clinical factors, infection prevention practices, 
and practice site differences associated with infectious complications (Uslan et al., 
2012).   
A single center study completed by Tischer et al. investigated the 
management and outcome of patients with pacemaker infections in a single center 
over four decades. Authors noted antibiotic regimes have changed over a period of 
time and assimilation of the guidelines improved the outcome of pacemaker 
infections (2014). In another study early recognition and treatment of infections, 
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aggressive management of hematomas, and use of antibiotic therapy with device 
revisions might help reduce the rate of infection (Raad et al., 2012).  
Each of the studies recommends intravenous antibiotic prophylaxis and 
protocols to reduce the risk. Few studies have assessed prophylactic use of oral 
post-op antibiotics after CEID implantation at discharge to further reduce the rate 
of infection (D. Uslan, Dowsley, & Sohail, 2010). With these gaps in the literature 
further research has been recommended and will be addressed in this project.  
Theoretical framework  
Benner’s clinical wisdom in nursing practice was the theoretical framework 
applied to analyze the population and data reviewed. Each of Benner’s seven 
domains could easily be applied however, the one domain specific to this study 
was monitoring and ensuring quality of healthcare practices (Masters, 2014). This 
domain was applicable in patient education post implant to identify signs and 
symptoms of infection, utilized in assessment of the patients incisional sites post 
procedure at follow-up appointments and evaluating if current practices was the 
consistent with evidenced based practices.  
CHAPTER 3: METHODOLOGY AND METHODS  
A retrospective population based cohort of patients was evaluated in a 
single center teaching institution over a three year period 2013-2016. This time 
frame was chosen as it coincided with the implementation of institutional 
electronic medical record (EMR) system for both clinic and hospital. Two patient 
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groups were evaluated, prophylactic post-operative oral antibiotics (Keflex and 
Doxycycline) compared with no prophylactic oral antibiotic at discharge to 
determine rate reduction of surgical site infection in CIED implants.  Inclusion 
criteria included patients implanted with an initial or replacement pacemaker, ICD 
or ILR by four Electrophysiologist (EP) within the group. Exclusion criteria; 
simple interventions on the scar; devices not implanted by Electrophysiologist 
team, device extraction, intervention on the same surgical site < 30 days after the 
first implantation for devices implanted in outside hospitals (OSH).  
The project included an evaluation of the each implanting physician and 
protocols for CIED implants of four EP (Figure 2).  The intervention was 
antibiotic prophylaxis implemented by a single implanting EP after a designated 
period, September 2015 to end of study period. Data collection for patients 
implanted with a CIED will be through a retrospective chart review. Evaluation 
included time frame of an in-office visit post procedure by a physician or 
Advanced practice registered Nurse (APRN)/Nurse Practitioner (NP) on EP team.  
No subjects were recruited for this retrospective study, they were identified in the 
manner described above.  There was no direct compensation to subjects. No 
consent was required as this was a retrospective chart review. There were no direct 
risks or benefits to subjects recruited to this study. There was no direct contact 
with patients additionally; the patients’ identities will not be identifiable in results 
from this investigation. Potential risk may include having the patient’s privacy or 
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confidentiality compromised.  But every reasonable effort was made to protect the 
patient’s information while their data is used as part of this study. 
Data Analysis 
 Data collection was gathered in a tertiary care university hospital by the 
primary investigator, and two research assistants, a Cardiology Nurse practitioner, 
and clinic medical assistant assigned to the EP team. The primary investigator 
conducted one on one training sessions with individuals assisting in data retrieval  
prior to data collection.  
 Patients were identified through a Cardiovascular lab specific data base and 
the EMR system. The project has approval by the institutional Nursing research 
council and California State University Nursing institutional review board. 
Variables included in the statistical analysis were; procedure date, length of stay, 
provider, device type, risk factors, initial or replacement devices, days to follow-
up and if antibiotics were prescribed at discharge. Data collection included patient 
location before and after the procedure, and if the patient was inpatient or 
outpatient through the EMR (Appendix A). Procedures or infections not clearly 
defined were excluded.  
CHAPTER 4:  RESULTS 
 Standard infection control methods were observed in pre-operative, 
intraoperative and post-operative period. Pre-operatively patients were screened 
for risk factors increasing risk of infection, patients showered in chlorhexidine the 
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night before and the morning of the procedure, chest hair was clipped, patients 
received intravenous antibiotics one hour before incision. Vancomycin was the 
antibiotic of choice unless allergies, as this institution has been deemed to have an 
increased risk for methicillin resistant streptococcus aureus (MRSA). Intra-
operatively patients chest were cleansed with betadine scrub neck to nipple, sterile 
techniques were observed by CVL or operating room staff, a sterile dressing was 
applied to incisional site before leaving the operative area. Post-operatively 
patients received a second dose or intravenous antibiotics as applicable and 
extensive wound care instructions were provided by an APRN with written 
instructions provided to patient and/or family. It was noted during post-op office 
visits that staff were not consistently utilizing infection prevention with equipment 
use. An additional intervention included educating staff to cleanse programmer 
head between each patient before application. There was no pre and post data 
analysis for this intervention. 
  Continuous variables were assessed with categorical variables using one -
way, two-way Anova and Tukey method to evaluate oral post op antibiotic use, 
incisional assessment, infection rates and time frame for follow-up as appropriate. 
Standard statistical methods were used in analysis of data collected using SPSS  
23 statistical program to run data analysis. 
Patient demographics included male 57.9%, female 42.1%.  The youngest 
was nineteen years old, the oldest was ninety-seven years old 47.3% were between 
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sixty-one and eighty years old, mean age was 65.8 years old, other characteristics 
are shown in Table 1.  
Table 1. Patient demographics 
Age Groups  Percentage 
19-30 y.o.  5.2% 
31-40 y.o.  4.0% 
41-50 y.o.  8.0% 
51-60 y.o.  17.1% 
61-70 y.o.  20.4% 
71-80 y.o.  26.9% 
81-97 y.o.  18.4% 
   
Gender  Percentage 
Male  57.9% 
Female  42.1% 
Ethnicity                    Percentage  
African American 10.8% 
Hispanic  19.8% 
Caucasian 62.5% 
Asian  4.8% 
Other  2.2% 
 
Twelve-hundred patient CIED patient encounters were implanted between  
 
2013 and 2016, ICD’s 50.6%, Pacemakers 42.2%, ILR 5.5, lead revision 1.8%.  
 
Both pacemaker and ICD initial implants were 64.3%, replacement 35.2%,  
 
and upgrades 11%. Statistical significance (P .030) was noted in provider and 
incisional assessment  and interaction between provider and antibiotic (P .019). 
Meaning, based on the provider and use of antibiotic there was a significance on 
incisional assessment.  
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Source df Sig. Partial Eta Squared 
Corrected Model 12 .000 .180 
Intercept 1 .001 .036 
Provider 3 .030 .028 
Antibiotics 3 .169 .016 
Provider * Antibiotics 6 .019 .047 
 
For this study infection was diagnosed based on incisional assessment by 
provider evaluation for symptoms of pain 17.8%, fever 1.0% and no symptoms 
81.2%. Patients incision were assessed for- no symptoms 79%, drainage 1.0%, 
swelling 10.4%, fluctuance 0.4%, erythema 0.2%, hematoma 1.4%, bruising 1.4%,  
patients with more than one finding was 5.8% as shown in Table 2. While 
symptoms were noted as outlined, no surgical site infections were identified in the 
population during the study time frame. Follow-up was within 6-15 days 71.2% 
(Nurse Practitioner 34.5%, Physician 56.1%, no follow-up 9.4%) in outpatient 
setting.  
Table 3 . Incisions assessed at post-op visit  
Incisional assessment              Percentage              
  
None 79.4 % 
Drainage 1.0  % 
Swelling 10.4 % 
Fluctuance 0.4 %  
Erythema 0.2 % 
Hematoma 1.4 % 
Bruising 1.4 %  
More than one symptom 5.8 %  
Table 2. Tests of Between-Subjects Effects Two way ANOVA results 
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The use of antibiotics in whole was not statistically significant when 
evaluating incisional assessment with a 95% confidence interval (CI).  Use of oral 
antibiotics consisted of Keflex 8.2%, Doxycycline 17.6%, other 3.8% and no 
antibiotic usage was 70.5%. No statistical difference was noted in implants 
between years for incisional site assessment.  
Risk factors to infection identified in analysis of this patient population 
consisted of diabetes 13.4%, dialysis 0.2%, anticoagulation 25.7%, temporary 
wires 0.8%. Patients also had multiple factors for increased risk of infection with 
the largest population figure in combined diabetes and anticoagulation 7.8% as 
detailed in Table 4.  
 
 
 
 
Comorbidities  Percentage 
Diabetes 13.4  %  
Dialysis 0.2    % 
Anticoagulation 25.7  % 
Temporary Wires 0.8   % 
DM, Dialysis 1.6   % 
DM, Anticoag 7.8  % 
DM, Temp Wires 0.2  % 
DM, Dialysis, Anticoag         1 .0  % 
Anticoag, Temp wires 0.6  % 
Table 4. Risk factors associated with increased risk of SSI 
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CHAPTER 5: CONCLUSION  
The increase in infections for patients implanted with a CIED has been 
identified in the literature. The project evaluated the use of oral post-op antibiotics 
in reducing the rate of infection. No infections were identified during the study 
period. The use of prophylactic post operative oral antibiotics in whole was not 
statistically significant.   
This was a retrospective analysis from a single center and thus subject to 
inherent limitations. However, the comparisons made were in subjects performed 
by the similar operators and facility. In addition, the large subject size may allow 
for application to the general public.  
Implications for Nursing and APRN practice includes improved patient 
outcomes, utilization evidenced based practice to prevent or minimize infection by 
adhering to infection control practices. Nursing will be able to apply knowledge 
obtained in the post-operative care of CIED patients through enhanced knowledge 
of cardiac device infection identification, appropriate use of antibiotics and when 
to refer to cardiac specialty.  
Recommendations for future research a prospective analysis of prophylactic 
oral antibiotics in low and high risk populations, adherence to pre-operative, peri-
operative and post-operative protocols. In addition we recommend consistently 
cleaning device programmer heads between patients as a part of infection 
prevention.  
 22
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APPENDIX A: DATA COLLECTION TOOL  
Implanting Physician  
Name   ID number  
Patient description  Risk factors  
Patient MRN 
Age (on date of 
procedure)  Diabetes  
   Dialysis 
Gender  Ethnicity  Anticoagulation  
Temporary Pacing wires  
Event details 
Date of procedure  
Procedure  
# of leads with 
initial  
Inpatient / Outpatient  Initial/Replacement  
Location/Unit   Upgrade  
Antibiotic prescribed  
Early 
Reintervention  
Incision Evaluation  
Assessment   Symptoms   Follow up  
Drainage  Pain or tenderness 
# of days to follow up 
appoint. 
Swelling or Fluctuance    fever   Physician /NP (APRN) 
Erythema    
Hematoma  
Warmth to touch  
Clinical diagnosis of Infection  
Legend  
Physician ID  Antibiotic Use  Secondary ID  
Provider 2   2  Doxy  2  Patient initials and age   
Provider 1  1  Keflex  1 
Provider 3  3  None  0 
Provider 4  4  Other  3  Number of Leads  
Procedure   Follow‐ up  Dual   2 
Pacemaker   1  Physician   1  Single   1 
ICD  2  NP   2  None   0 
Implantable loop recorder   3  Bi ‐ Ventricular   3 
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Figure 1  Surgical site infection  Centers for disease control – Retrieved from https://www.cdc.gov/hicpac/pdf/guidelines/SSI_1999.pdf
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Figure 2. Overview of study design 
 
 
 
 
 
 
 
 
 
 
APPENDIX C: RESEARCH DESIGN  
